Atazanavir for HIV Infected Individuals: An Early Access Program

Key inclusion criteria: * Patients eligible for inclusion into the EAP are those that are a virologic failure due to resistance, intolerance and/or adherence problems with current anti-HIV medications; * OR have multiple toxicities or intolerance to their anti-HIV medication but are not a virologic failure; * OR have severe elevated lipids in the blood (e.g., cholesterol, triglycerides) that do not respond to lipid-lowering medication. Key exclusion Criteria: * Restrictions apply regarding the use of atazanavir with specific medications which may have a potential to cause possible side effects when taken together. * Patients will also be excluded for any of the following reasons: 1) pregnancy or breast feeding, 2) elevated liver enzymes, 3) significant cardiovascular disease, or 4) other restrictions as indicated in the protocol.